Generate Biomedicines, Inc.

GENB· NASDAQ· Financials· Diversified Financials

$14.34+2.43%

2026-08-03

Financials

Valuation Metrics

Generate Biomedicines, Inc.'s Market Cap is $1.84B. Ranked #2119 of 3,111 in US market (top 68%), #822 of 1,445 on NASDAQ (top 57%), #121 of 161 in Financial Services (top 75%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.84B	US#2,119/3,111 Sec#121/161
Revenue	$32M	US#2,897/3,111 Sec#159/161
Net Income	$-203M	US—/3,111 Sec—/161
Total Assets	$330M	US#2,880/3,111 Sec#159/161
Net Assets	$-616M	US#3,044/3,111 Sec#162/161
Value
P/S	57.64x	US#2,892/3,111 Sec#159/161
FCF Yield	-11.10%	US—/3,111 Sec—/161
Profitability
ROA	-61.53%	US#3,015/3,111 Sec#161/161
Op. Margin	-737.04%	US#2,918/3,111 Sec#160/161
Revenue Growth	55.89%	US#265/3,111 Sec#16/161
Financial Health
Total Debt	$69M	US#2,513/3,111 Sec#143/161
FCF	$-204M	US#2,741/3,111 Sec#125/161
Cash	$122M	US#2,100/3,111 Sec#125/161
Current Ratio	2.85x	US#856/3,111 Sec#52/161
Performance
1M Return	-17.63%	US#2,707/3,111 Sec#142/161
From 52W High	-21.12%	US#1,805/3,111 Sec#98/161
1Y MDD	-26.20%	US#1,107/3,111 Sec#60/161
Trading
Volume	263,600 shares	US#2,346/3,111 Sec#117/161
Trading Value	$4M	US#2,678/3,111 Sec#141/161